Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

The World Economic Forum predicts that biodiversity loss could cause a colossal decline in global GDP of $2.7 trillion ...

Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, ...

Start-up Colossal Biosciences wants to bring back the woolly mammoth via gene editing. The company is on track to revive the ...

Colossal Biosciences is working to bring back species like the woolly mammoth using CRISPR-Cas9 technology. The project aims to restore lost biodiversity and combat climate change by creating cold ...

The US company, which is aiming to bring back extinct species, says that it expects its first woolly mammoth calves will be ...

(Bloomberg) -- A biotechnology startup working to bring back animals from extinction has raised $200 million at a valuation of $10.2 billion, more than six times its valuation just two years ago.

Imagine a world where the majestic woolly mammoth roams the Arctic tundra once again, thousands of years after its extinction ...

Biotech startup Colossal is reviving extinct species like the woolly mammoth, backed by $200M in funding and big-name ...

A startup company is trying to raise money to bring back the woolly mammoth. Colossal Biosciences Inc. uses DNA and genomics in hopes of re-introducing extinct animals to the modern-day world.